The retail and pharmaceutical industries have taken a hit amid culture war battles over the last two years, according to new polling released Wednesday by Gallup. Just 36 percent of Americans hold a positive view of the retail industry,
Pharmaceutical supply disruptions compromise medical care and may place patients’ health and even their lives at risk through treatment delays, rationing, increased likelihood of medication errors, and the substitution of possibly inferior alternatives.
Scotiabank analyst George Farmer maintained a Hold rating on BioMarin Pharmaceutical (BMRN – Research Report) today and set a price
Pharmaceutical Logistics Market size was valued at USD 227.45 billion in 2022 and is expected to reach USD 446.61 billion by 2030, at a CAGR of 8% during the forecast period 2023 to 2030. The growth of the pharmaceutical logistics market is driven by the …
The Scottsdale-based pharmaceutical company entered into an exclusive license agreement with Maruho Co. Ltd. to develop and commercialize its Qbrexza treatment for hyperhidrosis — excessive sweating — in several Asian countries including South Korea …
The start of a large investment project, worth over BGN 40 million, for the building of a pharmaceutical factory, an herb farm and a tourist complex was given in the village of Zidarovo, Sozopol Municipality,
The theme of this year’s event is Macro Impacts from the Micro Universe. The ever popular Ask the Regulators session returns. BETHESDA, Md., Sept. /PRNewswire-PRWeb/ — The Parenteral Drug Association,
Explore the thriving Rare Disease Clinical Trials Market Detailed Information about Each Segment, and Identify Key Trends, Drivers, and Challenges in the MarketNEWARK, Del, Sept. (GLOBE NEWSWIRE) — The rare disease clinical trials market has been growing prominently over the past few years.
Concerns about the impact of pharmaceutical agents on fetal development have prompted researchers at Iowa State University to undertake a key study using a placenta-on-a-chip model. The study, focused on the transport of naltrexone (NTX) and its primary metabolite 6β-naltrexol,
Concerns about the impact of pharmaceutical agents on fetal development have prompted researchers at Iowa State University to undertake a key study using a placenta-on-a-chip model. The study, focused on the transport of naltrexone (NTX) and its primary metabolite 6β-naltrexol,